Ind-Swift Laboratories share news, announcements and annual reports
NSE: INDSWFTLABBSE: 532305Pharmaceuticals & BiotechnologySmall Cap
Ind-Swift Laboratories Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jul 1997 on NSE, Mar 2000 on BSE
Last close ₹368.20down ₹41.60 (10.15%)BSE ₹367.40
Share price at the NSE close on 30 Oct 2026. Previous close ₹409.80.
30 Oct: open ₹417.90, high ₹426.60, low ₹352.35
52-week range of traded prices to 30 Oct 2026
₹87.15Low, 31 Dec 2025₹426.60High, 30 Oct 2026
- Under NSE's long-term additional surveillance, stage I, on the list for 30 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹3,202 Cr1,404th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 38.32
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹12 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 33.57
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.17
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 6.0%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹12 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 6.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 4.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.01
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 36,07,65931.1% delivered
Ind-Swift Laboratories results
71 filed, newest first. Page 2 of 2.
Aug 2014
May 2014
Feb 2014
10 Feb · Results
Nov 2013
12 Nov · Results
Aug 2013
12 Aug · Results
May 2013
Feb 2013
Nov 2012
Aug 2012
May 2012
2 May · Results
Company has decided to adopt the audited financial results for the year ending 2011-12 on or before May 30, 2012 instead of adopting Unaudited Quarterly Results for the quarter ended March 31, 2012.
Feb 2012
Nov 2011
Aug 2011
11 Aug · Results
May 2011
Apr 2011
19 Apr · Results
Company has decided to adopt the audited financial results for the year 2010-11 within 60 days of the closure of the last quarter instead of adopting unaudited quarterly results for the quarter ended March 31, 2011.
Jan 2011
Nov 2010
Apr 2010
29 Apr · Results
The Company has decided to adopt the audited financial results for the year 2009-10 within 60 days of the closure of the last quarter instead of adopting unaudited quarterly results for the quarter ended March 31, 2010.
Apr 2009
15 Apr · Results
Ind-Swift Laboratories Ltd. has informed the Exchange that the Company has decided to adopt the audited financial results for the year 2008-09 before June 30, 2009 instead of adopting unaudited quarterly results for the quarter ended March 31, 2009.
Apr 2008
15 Apr · Results
Ind-Swift Laboratories Ltd. has informed the Exchange that: "The Company has decided to adopt the audited financial results for the year 2007-08 before 30th June, 2008 instead of adopting unaudited quarterly results for the quarter ended 31st March, 2008".